Tetracaine Hydrochloride

Specifications

136-47-0CAS Number

205-248-5EC Number

2-(dimethylamino)ethyl 4-(butylamino)benzoate;hydrochlorideIUPAC Name

C15H25ClN2O2Chemical Formula

300.82 g/molMolecular Weight

Tetracaine hydrochloride; 136-47-0; Tetracaine HCl; Butethanol; Curtacain; Menonasal; Pantocaine; Anethaine; Dicainum; Amethocaine hydrochloride; Tetocaine; Tetraca; DTXSID6042448; 5NF5D4OPCI; NSC-757337; Pontocaine Hydrochloride; Tetracaini hydrochloridum; Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester, monohydrochloride; DTXCID4022448; KOVANAZE COMPONENT TETRACAINE HYDROCHLORIDE; Locan; Comfortox Tetracaine; RefChem:56113; NeuroMed Topical Analgesic; Eclipse Topical Analgesic LL; NeuroMed Topical Analgesic LA; 2-(Dimethylamino)ethyl 4-(butylamino)benzoate monohydrochloride; 205-248-5; Butylocaine; 2-(dimethylamino)ethyl 4-(butylamino)benzoate hydrochloride; Tetracaine (hydrochloride); 4-(Butylamino)benzoic Acid 2-(Dimethylamino)ethyl Ester Hydrochloride; Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester,monohydrochloride; MLS000069780; 2-Dimethylaminoethanol 4-N-butylaminobenzoate hydrochloride; 2-(Dimethylamino)ethyl p-(butylamino)benzoate monohydrochloride; MFCD00038912; Tetracaine hydrochloride (Pontocaine); 2-(dimethylamino)ethyl 4-(butylamino)benzoate;hydrochloride; Anethain; Decicain; Decicaine; Dessicain; Intercaine; Leocaine; Pantocain; SMR000058522; Tonexol; Anacel; Gingicain M; 53762-93-9; Tetracainium chloridum; Tetracaine chlorhydrate; Viractin; Tetracaine monohydrochloride; Amethocaine monohydrochloride; SR-01000075240; NCGC00016049-02; CAS-136-47-0; EINECS 205-248-5; UNII-5NF5D4OPCI; Exactacain; Tetracaine hydrochloride [USP:JAN]; p-Butylaminobenzoyl-2-dimethylaminoethanol hydrochloride; 2-(Dimethylamino)ethyl p-(butylamino)benzoate hydrochloride; Opera_ID_1220; Am ethocaine hydrochloride; p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester, hydrochloride; DICAINUM [WHO-IP]; Tetracaine hydrochloride CRS; SCHEMBL24370; MLS002222164; SPECTRUM1500564; CHEBI:9469; orb1309441; orb3025038; CHEMBL1255654; Tetracaine hydrochloride, >=99%; HMS1569D04; HMS1921C17; HMS5081J05; Pharmakon1600-01500564; HY-B0473; Tox21_110290; Tox21_501211; AC-774; CCG-39266; EBC-28048; NSC757337; s2573; TETRACAINE HYDROCHLORIDE [MI]; Tetracaine for system suitability CRS; Tetracaine hydrochloride (JP18/USP); TETRACAINE HYDROCHLORIDE [JAN]; AKOS015888160; Tox21_110290_1; FT28067; KS-5059; LP01211; NSC 757337; BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER, MONOHYDROCHLORIDE; TETRACAINE HYDROCHLORIDE [MART.]; TETRACAINE HYDROCHLORIDE [VANDF]; NCGC00016049-07; NCGC00094458-01; NCGC00094458-02; NCGC00094458-03; NCGC00094458-04; NCGC00094458-05; NCGC00261896-01; TETRACAINE HYDROCHLORIDE [USP-RS]; TETRACAINE HYDROCHLORIDE [WHO-DD]; TETRACAINE HYDROCHLORIDE [WHO-IP]; AMETHOCAINE HYDROCHLORIDE [WHO-IP]; DB-042341; EU-0101211; NS00079216; SW196411-3; TETRACAINE HYDROCHLORIDE [GREEN BOOK]; TETRACAINE HYDROCHLORIDE [ORANGE BOOK]; D00741; T 7508; TETRACAINE HYDROCHLORIDE [EP MONOGRAPH]; TETRACAINE HYDROCHLORIDE [USP MONOGRAPH]; EN300-6748838; TETRACAINI HYDROCHLORIDUM [WHO-IP LATIN]; Tetracaine hydrochloride, Sigma Reference Standard; SR-01000075240-1; SR-01000075240-6; Q27262597; Z2756516968; Tetracaine hydrochloride, meets USP testing specifications; 2-(Dimethylamino)ethyl 4-(butylamino)benzoic acid hydrochloride; Tetracaine Hydrochloride 1.0 mg/ml in Acetonitrile (as free base); 2-(Dimethylamino)ethyl 4-(butylamino)benzoate--hydrogen chloride (1/1); Tetracaine hydrochloride, European Pharmacopoeia (EP) Reference Standard; Tetracaine for system suitability, European Pharmacopoeia (EP) Reference Standard; Tetracaine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Tetracaine hydrochloride, United States Pharmacopeia (USP) Reference StandardSynonyms